By Ikechukwu Kelechukwu | Project Leader
Dear Partners,
Innovation has always been at the heart of public health progress. From vaccines to new treatment approaches, scientific advances have transformed millions of lives worldwide.
Today, long-acting HIV prevention offers another opportunity for progress. Lenacapavir represents a major advancement because it addresses one of the biggest challenges in HIV prevention: adherence. By reducing the need for daily medication, it helps make prevention more practical for many adolescents.
Empower Future Initiative is preparing to help communities understand and embrace this innovation. Through awareness campaigns, community outreach, and youth engagement activities, we hope to build trust and support for modern HIV prevention strategies.
Our first donors have already demonstrated confidence in this mission, and we are grateful for their support. However, achieving meaningful impact will require a broader coalition of supporters.
We invite donors, foundations, businesses, and healthcare advocates to join us. Together, we can help ensure that innovation reaches the young people who need it most.
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser
